Pharmacokinetic properties of an escherichia-coli-produced recombinant plasminogen activator (BM 06.022) in rabbits
- 1 May 1991
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 62 (3) , 137-146
- https://doi.org/10.1016/0049-3848(91)90188-3
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cellsThrombosis Research, 1990
- Pharmacokinetics and Coronary Thrombolytic Properties of Two Human Tissue-Type Plasminogen Activator Variants Lacking the Finger-Like, Growth Factor-Like, and First Kringle Domains (Amino Acids 6–173) in a Canine ModelJournal of Cardiovascular Pharmacology, 1990
- Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1989
- Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1989
- Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbitsBlood, 1988